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Severe refractory asthma affects all age-groups [1] [2] [3] . The prevalence of asthma in the elderly 99 ranges from 7% to 11% 4-6 , and with the expected increase in the proportion of elderly people 100 in the population worldwide 4, 5, 7 , understanding the phenotype of asthma in the elderly will 101 be of great importance. Asthma in older people is believed to be under-diagnosed, under-102 treated and often associated with worse health care outcomes 5, [8] [9] [10] [11] . Co-morbid conditions, 103 the psychosocial effects of ageing and reduced perception of bronchoconstriction 12 as well as 104 altered airway inflammation 8, 13, 14 may contribute to worse clinical outcomes in elderly 105 asthmatics 8, 9 . 106 107 To date however, there is limited information on clinical and physiological outcomes and 108 immunological biomarkers of inflammation in older people (aged > 65 years) with severe 109 refractory asthma compared with younger patients (aged < 65 years) with severe disease 15 . In 110 patients recruited to the American Severe Asthma Research Programme (SARP) the probability 111 of severe disease increased with each year of life until the age of 45 years and thereafter 112 increased at a slower rate 16 . Clinical research trials, especially phase 2 studies, frequently 113 exclude subjects aged >65 years 14 . It is important to know whether clinical and inflammatory 114 variables in this group differ from younger patients when utilising new therapies for severe 115 asthma. 116 117 Age of asthma onset within the general adult asthma population can affect clinical and 118 inflammatory variables 17, 18 . Early-onset adult asthma is associated with poor symptom 119 control and atopy 18, 19 , whereas adult-onset asthma is associated with female gender, current 7 smoking and greater airflow obstruction 18 . Severe adult-onset asthma may be a distinct 121 phenotype compared to milder forms of adult-onset asthma 20 as it is associated with a 122 greater proportion of non-atopics, worse nasal symptoms, and higher levels of inflammatory 123 biomarkers such as exhaled nitric oxide, blood neutrophils and sputum eosinophils 20 . Adults 124 with early-onset severe asthma have more allergic symptoms, greater allergen sensitivity and 125 less lung eosinophilia than people with severe late-onset asthma 21 . A systematic review of 126 four studies of adults with severe early-onset and late-onset asthma, with sample sizes 127 ranging from 74 to 275 subjects, identified few phenotypic differences due to age of onset 18 . 128
129
The British Thoracic Society (BTS) Difficult Asthma Network developed a National Registry for 130 dedicated UK Difficult Asthma Services 3 . We analysed this Registry population to examine the 131 8 assessment protocols, to ensure identification of patients with well-characterised refractory 145 asthma and data was collected at the time of referral to the centre. Subjects provide fully 146 informed written consent for their data to be held in the registry. The Northern Ireland 147
Research Ethics Committee approved research analysis of the data. To analyse the effects of 148 age, the cohort was divided into those ≥65 years and compared with those <65 years of age. 149
For effects of age of onset of asthma, the cohort was divided into childhood-onset of asthma, 150 if asthma symptoms started before the age of 18 years and adult-onset, if symptoms of 151 [20.7% versus 4.5%, p<0.001) and a smaller proportion had a history of perennial rhinitis 208 [23.2% versus 37.7%, p=0.001]. Femoral neck bone density was lower in the older group [T-209 score -1.1 (-1.7, 0.1) versus -0.2 (-1, 0.6), p<0.001]; the difference in spinal bone density 210 showed a trend to be worse in elderly patients (p=0.062). 211
Biomarkers of inflammation: FE NO50 and the proportion of sputum eosinophils and neutrophils 212
were similar in both groups, but blood eosinophils were lower in the elderly group [0.20 (0.10, 213 0.41) versus 0.29 (0.12, 0.56) x10 9 , p=0.014]. There was no difference in numbers of atopic
Severe asthma patients with age of onset < 18 years (childhood-onset) compared with those 217 aged ≥ 18 years (adult-onset) 218 219
Comparison of demography, clinical and inflammatory characteristics in patients with onset of 220 asthma at age <18 (n=430) and ≥ 18 years (n=526) is shown in Table 2 . 221
Demography: Adult-onset asthmatics compared to childhood-onset asthmatics had a slightly 222 higher BMI and lower proportion of never-smokers. The proportion of current smokers was 223 similar in both groups (9.1% and 9.7% respectively), although childhood-onset asthmatics had 224 a lower pack-year smoking history. 225
Clinical characteristics: Adult-onset asthmatics compared to childhood-onset asthmatics had a 226
shorter duration of asthma (16 years versus 36 years, p<0.001). The adult-onset group 227 administered slightly lower doses of inhaled corticosteroid and fewer rescue SABA puffs and 228 had a similar oral steroid maintenance dose. ACQ, AQLQ, lung function, rescue oral steroid 229 courses and hospital admissions were similar in both groups, whereas total number of ITU 230 admissions in the past year was higher in those with childhood-onset asthma (0.58 [1.60] In 1042 adults with refractory asthma recruited to the UK BTS Severe Asthma Registry we 245 investigated the effects of age and age of asthma onset on clinical characteristics and 246 biomarkers of inflammation in sub-groups of people with severe asthma who were elderly 247 (aged ≥65 years) or under 65 years of age and who had adult-onset or childhood-onset 248 asthma. Definitions of elderly asthma vary in the literature, but the commonly accepted cut-249 off is 65 years of age 6, 7 as it combines chronological and socio-cultural dimensions. To define 250 childhood-onset asthma and adult-onset asthma, we chose a cut-off age of 18 years, as it is 251 the commonly accepted age of the start of adulthood and streamlines with recent publications 252 on severe adult-onset asthma 17, 20 . 253 254 Asthma in the elderly is associated with worse health care outcomes 5, 8, 9 , although previous 255 studies have not investigated clinical and inflammatory outcomes in elderly patients with 256 severe disease. Contrary to the published evidence that ageing might worsen asthma in the 257 general population, we found that patients with severe refractory asthma above the age of 65 258 years had better asthma control than adults aged <65 years with severe asthma, as assessed 259 by lower ACQ, improved asthma quality of life and less oral steroid courses, as well as reduced 260 unscheduled emergency visits and fewer hospitalisations. Our data do not explain the 261 improved clinical and health care outcome in the elderly group, although there are several 262 possible factors that should be considered. There were differences in smoking status between 13 the groups, with a lower number of current smokers and a higher proportion of ex-smokers in 264 the group aged ≥65 years. The higher proportion of current smokers in the younger patients 265 may explain their increased morbidity from asthma, since smokers with severe asthma exhibit 266 worse clinical and health-care outcomes compared with ex-smokers and never smokers with 267 severe asthma 26, 27 . The elderly patients were not prescribed more treatment for asthma 268 compared with the younger group, as the latter group received slightly higher daily doses of 269 inhaled and oral corticosteroid. Non-adherence with medications occurs commonly in the 270 elderly 28 , although a survey of a large population of patients with Type 2 diabetes mellitus 271 reported that the 18-64 year age group had poorer medication adherence than the >65 year 272 age group 29 . Whether better adherence to medication occurs in an elderly severe asthma 273 population is not known. Co-morbid conditions such as depression may adversely influence 274 asthma control in the elderly with mild to moderate asthma 30 , but in our study anxiety and 275 depression scores were similar between the elderly and younger groups with severe asthma. . found in patients with severe asthma, which have been identified mainly on the basis of 287 induced sputum cell profiles in patients aged predominantly younger than 65 years 35, 36 . We 288 found that elderly patients with severe asthma had similar sputum eosinophils, sputum 289 neutrophils and exhaled nitric oxide measurements compared with younger patients with 290 severe asthma. Airway neutrophilia has been associated with ageing in a population of 291 healthy subjects and patients with asthma that included a high proportion (29.2%) of smokers 292 in the older asthmatic group 37 . The lower proportion of current smokers in the severe 293 asthmatic group in our study may in part explain why the sputum neutrophil count was not 294 increased in the elderly patients. In keeping with our findings, a previous report noted similar 295 sputum neutrophil counts in elderly patients with severe asthma (>60 years) compared to 296 younger adults 38 . Atopy levels were similar in the elderly and younger severe asthma groups. 297
Further research is indicated to investigate factors accounting for the better clinical outcomes 298 found in the older severe asthma group, including whether this due to altered airway 299 inflammatory processes in the elderly. The spectrum of inflammatory variables in elderly 300 patients with severe asthma suggests that this group should be considered eligible for clinical 301 trials of targeted biological therapies. 302
303
Severe adult-onset asthma is reported to be associated with a greater proportion of non-304 atopics, more severe disease and lower lung function, whereas childhood-onset asthma is 305 often associated with atopy and a good prognosis 17, 39 . There is limited information about 306 whether the clinical characteristics in severe late-onset asthma are similar to adults with 307 severe early-onset asthma. A comparison of adults with severe childhood-onset asthma 308 (n=87) with severe adult-onset asthma (n=63) reported that adult-onset patients had a shorter 309 duration of asthma and were receiving a lower dose of inhaled corticosteroid, but that the two 310 groups had similar impairment in lung function, requirements for oral corticosteroids and 311 responsiveness to corticosteroids in vitro 40 . Adults with severe asthma that first developed 312 before age 12 years have more allergic symptoms, higher levels of atopy and less lung 313 eosinophilia than people with severe late-onset asthma 21 . A systematic review of four studies 314 comparing severe early-and late-onset asthma in adults, identified few phenotypic 315 differences due to age of asthma onset 18 . In a large population of patients with severe asthma 316 we confirmed that adult-onset asthmatics (onset ≥ 18 years, n=430) compared to adults with 317 childhood-onset asthma (n=526) had a shorter duration of asthma, received slightly lower 318 doses of inhaled corticosteroids and had similar lung function and requirements for oral 319 corticosteroids. In addition, the adult-onset group had a higher proportion with a history of 320 nasal polyps and similar symptom control, health care utilisation and number of current 321 smokers compared to severe childhood-onset asthma. Taken together, these findings suggest 322 that despite the shorter duration of disease, adults with severe adult-onset asthma compared 323 to adults with severe early-onset asthma have similar clinical characteristics, except that the 324 adult-onset group are more likely to have nasal polyps. 325 326 Inflammatory biomarkers differed between adult-onset and childhood-onset severe asthma. 327
The adult-onset group had higher blood eosinophils and higher FE NO50 levels but similar 328 sputum cell counts. In addition, the late-onset asthmatics were less atopic and had lower total 329 IgE concentrations in keeping with a previous report 40 . A study of severe adult-onset asthma 330 reported higher FE NO50 , higher blood neutrophils, higher sputum eosinophils and less atopy 331 compared to mild asthma 20 . The FE NO50 levels were similar to our patient group, but induced 332 sputum neutrophils and eosinophils counts were lower, possibly because of higher doses of 333 inhaled corticosteroids suppressing eosinophils in our patient group. Taken together, these 334 finding suggest that patients with adult-onset severe asthma have elevated FE NO50 levels and 335 are less atopic. In addition, they are more likely to have a blood eosinophilia compared to 336 childhood-onset severe asthma. 337
338
Major strengths of the study were that over a thousand patients with severe asthma were 339 included in the analyses and these patients had all undergone a systematic assessment 340 protocol to ensure identification of patients with well-characterised refractory asthma. We 341 recognise that there are limitations in this study, in part due to undertaking a retrospective 342 study on registry data. Recall bias may influence the accuracy of some clinical outcomes such 343 as age of onset of asthma, duration of disease and frequency of health care utilization. There 344 was incomplete data for some outcome measures including sputum cytology; however, 345 sputum induction was performed in a similar proportion of elderly versus younger patients (38 346 out of 146 versus 179 out of 896, chi-sq=2.8, p=0.095) and thus representative of each group, 347
whereas a lower proportion in the adult-onset versus childhood-onset groups (70 out of 430 348 versus 134 out of 526, chi-sq=13.0, p<0.001). The tests, such as spirometry, lung volumes and 349 bone density, although standardized, were performed using different equipment across the 350 sites, as this data was collected from outpatient clinics and not in the setting of a research 351 trial. 352
353
In conclusion, we have demonstrated that elderly patients with severe refractory asthma 354 exhibit better clinical and health care outcomes and lower peripheral blood eosinophil counts 355 compared to those aged <65 years with severe disease, although the older patient group still 356 experience considerable morbidity due to asthma. Patients with severe adult-onset asthma 357 had similar outcomes for a range of clinical and health care variables compared to severe 358 childhood-onset asthma, but had raised blood eosinophils counts and were less atopic. Future 359 studies should include investigation of the pathogenic mechanisms in severe asthma in the 360 elderly and in severe adult-onset asthma as well as identifying target therapies for these 361 populations that have poorly controlled disease. 362 363 ACKNOWLEDGEMENTS 364
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